Bullous Pemphigoid (BP180 and BP230) Antibodies, IgG by ELISA
Ordering Recommendation
Use to monitor disease in patients diagnosed with pemphigoid and increased IgG BP180 and/or BP230 antibody levels. For initial pemphigoid diagnosis that discriminates among immunobullous diseases and for assessment of disease progression/changes and intermittent monitoring, the Basement Membrane Zone Antibody Panel (3001410) or Immunobullous Disease Antibody Panel (3001409) is preferred. In a relevant clinical setting, consider Pemphigoid Gestationis, Complement-Fixing Basement Membrane Antibodies (Herpes Gestationis Factor) (0092283).
For more information about components, methodology, and specimen type, see the ARUP Immunobullous Disease Testing Comparison tool.
New York DOH Approval Status
Specimen Required
Plain red or serum separator tube (SST).
Transfer 2 mL serum to an ARUP Standard Transport Tube. (Min: 0.5 mL)
Refrigerated.
Hemolyzed or lipemic specimens. Plasma.
Ambient: 1 week; Refrigerated: 2 weeks; Frozen: Indefinitely
Methodology
Semi-Quantitative Enzyme-Linked Immunosorbent Assay
Performed
Varies
Reported
3-11 days
Reference Interval
By report
Interpretive Data
Refer to report
Performed by non-ARUP Laboratory
Note
For specimens less than 0.5 mL, call the Immunodermatology Laboratory at (866) 266-5699.
Hotline History
Hotline History
CPT Codes
83516 x2
Components
Component Test Code* | Component Chart Name | LOINC |
---|---|---|
0092568 | Bullous Pemphigoid Antigens, IgG | 57911-0 |
2010915 | EER Bullous Pemphigoid Antigens, IgG |
Aliases
- BP 180 and BP 230
- BP Antigen 1
- BP Antigen 2
- bullous pemphigoid
- Bullous Pemphigoid (180 & 230) Antigens
- bullous pemphigoid antigen 1 or BPAg1
- bullous pemphigoid antigen 2 or BPAg2
- collagen type 17
- hemidesmosomal protein antibodies
- hemidesmosome antibodies
- herpes gestationis
- NC16A
- pemphigoid gestationis
- pemphigoid variants, IgG BP 180 and BP 230
- type XVII collagen, collagen type XVII